Brighter signs agreement to launch the diabetes solution Actiste in Indonesia.

Report this content

Brighter has chosen Indosat Ooredoo in cooperation with Ericsson as partners for the launch of Actiste in Indonesia. The solution will be launched based on the Ericsson’s DCP (Device Connection Platform) for Connectivity Management.

Diabetes is growing fast in the region and in 2015 about 10 million people live with the disease in Indonesia and another 5 million are undiagnosed, according to the International Diabetes Foundation. Actiste will be marketed and sold as a subscription service to both consumers and the healthcare sector. One key driver for Brighter’s focus on Indonesia is that healthcare is a priority investment in both public and private sectors. In 2014 the government of Indonesia launched a national health plan that includes diabetes treatment, including medical devices such as Actiste and digital services.

“We are very pleased to take another step further in the launch of Actiste in the Southeast Asian market along with one of Indonesia’s foremost mobile operators. Indosat Ooredoo, already heavily committed in the digitization of Indonesia, is a perfect partner for the launch of Actiste. Now we can intensify the work to help the millions of people living with diabetes that, on a daily basis, need to measure blood glucose and inject insulin. The Actiste subscription service will not only make daily routine simpler, it will also allow for better follow up and prioritization from the healthcare professionals, supported by The Benefit Loop. This is what the doctors are needing to dramatically improve the outcome of the treatment and reduce consequential damages such as foot amputations, dialysis, stroke, to mention a few, says Truls Sjöstedt, Brighter's CEO and founder.

”We are pleased that our strategic engagements with global/international OEM´s is leading to business agreements for our operator partners offering DCP as a Service. Our partnership with Brighter and leading local telecom operator will enable an improved and more efficient healthcare sector in Indonesia, bringing the nation one step closer to becoming a truly Networked Society, in which individuals, in this case diabetes patients, are empowered to better manage their health and wellbeing.”, says Thomas Jul, Head of Customer Unit Indonesia & Timor Leste at Ericsson.

The launch is scheduled for late 2017, following Actiste’s CE-marking, launch in Sweden and local regulatory registration.

For more information, please contact:

Truls Sjöstedt, CEO 
Tel: +46 709 73 46 00 
Email: truls.sjostedt@brighter.se 

Henrik Norström, COO 
Tel: +46 733 40 30 45 
Email: henrik.norstrom@brighter.se

About Actiste.
Brighter’s Diabetes Management subscription service solution Actiste® simplifies insulin-treated diabetes by gathering all the most important functions in a connected device with which the person living with diabetes can measure blood sugar levels, set dosage and inject insulin, as well as automatically log and share information.

About Brighter AB.
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX FIRST NORTH/BRIG. Brighter's Certified Adviser is Remium Nordic AB, +46 (0)8 454 32 50, CorporateFinance@remium.comwww.remium.com.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on November 30 2016.

Tags:

Subscribe

Documents & Links